FDA DEVICE FACTS
Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C2 Coronary Intravascular Lithotripsy (IVL) Catheter
Shockwave Medical, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
Intravascular Lithotripsy System Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C 2 Coronary Intravascular Lithotripsy (IVL) Catheter QMG Shockwave Medical, Inc. 5403 Betsy Ross Drive Santa Clara, CA, USA None P200039 February 12, 2021 Granted breakthrough device status on August 19, 2019 because the device and the proposed indication for use meet the criteria to be granted designation as a Breakthrough Device. The Shockwave Intravascular Lithotripsy (IVL) System with Shockwave C 2 Coronary IVL Catheter is indicated for lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic de novo coronary arteries prior to stenting.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。